Florida's Premier Medical Cannabis Clinic

Medical Cannabis in the Elderly, Safety and Efficacy Study

Elderly marijuana patients
Table of Contents

A recent study published by the European Journal of Internal Medicine found that the therapeutic use of cannabis is “safe and efficacious” in the elderly population. Researchers also concluded that marijuana may decrease the use of other prescription medicines, including opioids.

Marijuana and the elderly: Study results

According to researchers at Ben-Gurion University of the Negev (BGU) and the Cannabis Clinical Research Institute at Soroka University Medical Center, medical marijuana can “significantly” reduce chronic pain in patients ages 65 and older without adverse effects.

The new study, published by The European Journal of Internal Medicine, found that elderly patients were able to safely use cannabis to treat cancer symptoms, Parkinson’s disease, post traumatic stress disorder, Crohn’s disease, multiple sclerosis, and a number of other medical conditions.

As Dr. Victor Novack, head of the Soroka Cannabis Clinical Research Institute, explains:

While older patients represent a large and growing population of medical cannabis users, few studies have addressed how it affects this particular group, which also suffers from dementia, frequent falls, mobility problems, and hearing and visual impairments.

After monitoring patients 65 and older for six months, we found medical cannabis treatment significantly relieves pain and improves quality of life for seniors with minimal side effects reported.

Research methods

BGU researchers surveyed 2,736 patients ages 65 years and older who used medical marijuana. More than 60% were prescribed medical cannabis due to pain, particularly pain associated with cancer. After six months of treatment, more than 93% of 901 respondents reported their pain dropped from a median of eight to four on a 10-point scale.

Close to 60% of patients who originally reported “bad” or “very bad” quality of life upgraded to “good” or “very good” after six months. More than 70% of patients surveyed reported moderate to significant improvement in their condition.

The most commonly reported adverse effects were dizziness (9.7%) and dry mouth (7.1%). After six months, more than 18% of patients surveyed had stopped using opioid analgesics or had reduced their dosage.

More than 33% of patients used cannabis-infused oil, approximately 24% inhaled therapy by smoking, and approximately 6% used vaporization.


Questions about medical marijuana? Ready to get your card and purchase legal cannabis products? CannaMD‘s state-certified network of medical marijuana doctors are here to help! Contact CannaMD‘s experienced team at (855) 420-9170 today. You can also find out if you qualify for medical marijuana treatment with our quick online application!

Find Out If You Qualify

You may be eligible for medical marijuana!
To stay up-to-date with the latest studies and legal regulations surrounding medical marijuana treatment, be sure to follow CannaMD on Facebook and sign up for our newsletter, below!

Join 100k+ Subscribers!

Get updates on more posts like this!

Author Bio

Jessica Walters

Jessica Walters serves as CannaMD's Chief Medical Researcher. Prior to her time at CannaMD, Jessica graduated from Harvard where she focused on neuropsychology. Her personal research interests include psychosocial interventions for obesity, depression, and generalized anxiety disorders.
Related PostS

Feedback from our readers is very important and helps us provide quality articles. Please don’t be shy, leave a comment.

If you have a topic you would like us to cover in our blog or you are interested in writing guest posts please contact us for more information.

Get a medical marijuana certification in Florida